Corporate News Update – Market Activity for Outset Medical, Inc.
Date of Report: 20 October 2026Reporting Time: 11:46 PM Central Europe time (CET)
Outset Medical (Ticker: OM)
| Item | Value |
|---|---|
| Last closing price | USD 4.22 |
| 24‑hour change | ‑3.55 % |
| Current supply of shares | 18.8 million |
| Market capitalization | USD 74.1 million |
| 24‑hour trading volume | USD 225 k |
| Since last month‑end | +21.79 % |
| 200‑day simple moving average | USD 4.17 |
| 52‑week high | USD 15.94 (23 Oct 2025) |
| 52‑week low | USD 2.84 (28 Sep 2026) |
The share price of Outset Medical declined 3.55 % during the 24‑hour period ending at 11:46 PM CET on Tuesday, 20 October 2026. At the time of reporting, the stock traded at USD 4.22 on major exchanges. The company’s market capitalization stands at USD 74.1 million, and the volume of shares exchanged in the last 24 hours totaled USD 225 k. Since the end of the previous month, the stock has increased 21.79 %. The 200‑day simple moving average is USD 4.17. Over the past 52 weeks, the highest price reached USD 15.94 on 23 October 2025, while the lowest price was USD 2.84 on 28 September 2026.
Comparison with Related Stocks (Last 24 Hours)
| Company | 24‑hour change | Current price (USD) | Market cap (USD million) | P/E ratio |
|---|---|---|---|---|
| Connection (RGP) | –0.39 % | 2.46 | 88.5 | – |
| Flanigan’s (BDL) | –1.39 % | 48.15 | 88.5 | 13.39 |
| Rallybio (RLYB) | +0.43 % | 16.38 | 86.5 | 2.03 |
| Corbus Holdi (CRBP) | –1.33 % | 4.42 | 87.4 | – |
| Zerostack (ZSTK) | –2.75 % | 3.71 | 87.3 | – |
Additional Disclosure – Zerostack Corp. (ZSTK)
On 19 October 2026, Zerostack Corp. filed a Schedule 13G reporting significant holdings of its common stock by several investment entities. The filing lists ownership stakes ranging from a few thousand shares to over 1.6 million shares, comprising a combined ownership of several percent of the company’s outstanding shares. The report confirms that the shareholders are not holding the securities for the purpose of influencing control of the issuer. A joint filing agreement accompanies the disclosure, indicating that all listed entities consent to the joint submission of the Schedule 13G. The filing includes the company’s Dallas headquarters address and the principal executive office of the reporting parties, located in Palo Alto, California. The submission is signed by the general counsel of Hack VC Management, LLC and by Alexander Pack, identified as the managing member of the reporting group, providing a clear picture of the current beneficial ownership structure of ZeroStack Corp.
Company Overview – Outset Medical, Inc.
Outset Medical, Inc. is headquartered in San Jose, United States. The company specializes in the development of hemodialysis systems for kidney patients. Its mission is to revolutionize kidney patient care through innovative medical technology.